FFAR2 and cancer: SCFAs, such as acetate (an FFAR2 ligand), propionate (an FFAR2 and FFAR3 ligand), and butyrate (an FFAR3 ligand), have been shown to suppress inflammation and cancer [12, 13], and are thereby considered potential agents for cancer intervention [6, 14, 15].